Trinity Biotech plc (NASDAQ:TRIB) Q4 2022 Earnings Call Transcript

Page 5 of 5

Aris Kekedjian: Thank you. John and I appreciate the time you all took today to spend with us and to get an update on our journey. I feel very confident in terms of the progress we’re making and the focus of the organization. I think the first phase is well underway, but we have a lot of execution in front of us. We’re not delusional. This takes time. But we have a clear three-year plan and that’s where we’re executing against. Thank you for your time and we hope to speak to you again in the next couple of months’ time. Thank you.

John Gillard: Thank you everybody.

Operator: The conference is now concluded. Thank you for attending today’s presentation. You may now disconnect.

Follow Trinity Biotech Plc (NASDAQ:TRIB)

Page 5 of 5